Dr Stephen Scott Shaw, PHARM D in Andale, KS - Pharmacist

Dr Stephen Scott Shaw, PHARM D is a Pharmacist based in Andale, Kansas. Dr Stephen Scott Shaw is licensed to practice in Georgia (license number RPH023700) and his current practice location is 2301 N 219th St W, Andale, Kansas. He can be reached at his office (for appointments etc.) via phone at (678) 481-6392.

NPI number for Dr Stephen Scott Shaw is 1134422132 and his current mailing address is 2301 N 219th W, Andale, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1134422132.

Contact Information

	Dr Stephen Scott Shaw, PHARM D
	2301 N 219th St W, Andale, KS 67001-9521
	(678) 481-6392
	Not Available

Healthcare Provider's Profile

Full Name	Dr Stephen Scott Shaw
Gender	Male
Speciality	Pharmacist
Location	2301 N 219th St W, Andale, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1134422132
Provider Enumeration Date: 12/13/2010
Last Update Date: 12/13/2010

Medical Identifiers

Medical identifiers for Dr Stephen Scott Shaw such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1134422132	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	RPH023700 (Georgia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Stephen Scott Shaw is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Stephen Scott Shaw, PHARM D 2301 N 219th W, Andale, KS 67001 Ph: (678) 481-6392	Dr Stephen Scott Shaw, PHARM D 2301 N 219th St W, Andale, KS 67001-9521 Ph: (678) 481-6392

News Archive

Study provides new insights into how viruses establish chronic infections

Walter and Eliza Hall Institute researchers in Melbourne, Australia, have discovered how a key viral gene helps viruses evade early detection by the immune system. Their finding is providing new insights into how viruses are able to establish chronic infections, leading scientists to reevaluate their approaches to viral vaccine development.

New iHeal project aims to detect drug cravings and prevent medication use

Imagine a device combining sensors to measure physiological changes. Then imagine a smartphone with software applications designed to respond to your bodily changes in an attempt to change your behavior. That is the vision behind "iHeal," currently being developed- by Edward Boyer from the University of Massachusetts Medical School in the US, and his colleagues.

Researchers discover novel compounds that are hundreds of times more mutagenic

Researchers at Oregon State University have discovered novel compounds produced by certain types of chemical reactions - such as those found in vehicle exhaust or grilling meat - that are hundreds of times more mutagenic than their parent compounds which are known carcinogens.

Therapure Biopharma to fill/finish nimotuzumab at its Canadian GMP certified fill suite

David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).

Dr Stephen Scott Shaw, PHARM D - Pharmacist in Andale, KS